Literature DB >> 18162366

Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.

Richard E Jones1, Nicole Moes, Heather Zwickey, Christopher L Cunningham, William L Gregory, Barry Oken.   

Abstract

We have initiated studies to evaluate the suitability of performing therapeutic conditioning trials in experimental autoimmune encephalomyelitis (EAE) mice treated with alpha lipoic acid (ALA). EAE was induced in SJL mice by active immunization with myelin antigen. Once daily subcutaneous injection of ALA served as the unconditional stimulus (US) administered with the conditional stimulus (CS) saccharin-flavored drinking water under a regimen of restricted water access. In the first study, we found that water restriction and saccharin administration were compatible with disease development and effective ALA treatment of EAE mice. In the second study, mice were conditioned to once daily administration of ALA paired with administration of saccharin-flavored water (US+CS) on days 7-16. Test trials spanned experimental days 17-32 in groups receiving either saccharin-flavored water (CS, in the experimental group) versus unflavored water (CSo, in the control group) and compared several measures of EAE severity using multivariate ANOVA (MANOVA). Reduced disease severity in the experimental group (US+CS:CS) compared to the control group (US+CS:CSo) suggested that conditioning had occurred. These results demonstrate an approach for conducting therapeutic conditioning trials in EAE mice and suggest considerations for future investigations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162366      PMCID: PMC2435499          DOI: 10.1016/j.bbi.2007.10.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  20 in total

1.  Conditioned enhancement of antibody production is disrupted by insular cortex and amygdala but not hippocampal lesions.

Authors:  V Ramírez-Amaya; F Bermúdez-Rattoni
Journal:  Brain Behav Immun       Date:  1999-03       Impact factor: 7.217

2.  Murine taste-immune associative learning.

Authors:  Maj-Britt Niemi; Gustavo Pacheco-López; Wei Kou; Margarete Härting; Adriana del Rey; Hugo O Besedovsky; Manfred Schedlowski
Journal:  Brain Behav Immun       Date:  2006-04-21       Impact factor: 7.217

Review 3.  Behavioral conditioning of the immune system.

Authors:  Frank Hucklebridge
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 4.  Neurobiological mechanisms of the placebo effect.

Authors:  Fabrizio Benedetti; Helen S Mayberg; Tor D Wager; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

5.  Acquisition with partial and continuous reinforcement in pigeon autoshaping.

Authors:  Daniel A Gottlieb
Journal:  Learn Behav       Date:  2004-08       Impact factor: 1.986

Review 6.  Statistical analysis of data from studies on experimental autoimmune encephalomyelitis.

Authors:  Kandace K Fleming; James A Bovaird; Michael C Mosier; Mitchell R Emerson; Steven M LeVine; Janet G Marquis
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

Review 7.  Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology.

Authors:  Gustavo Pacheco-López; Harald Engler; Maj-Britt Niemi; Manfred Schedlowski
Journal:  Brain Behav Immun       Date:  2006-08-02       Impact factor: 7.217

8.  Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis.

Authors:  Gail H Marracci; Richard E Jones; Gabriel P McKeon; Dennis N Bourdette
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

9.  Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation.

Authors:  M S Exton; S von Hörsten; M Schult; J Vöge; T Strubel; S Donath; C Steinmüller; H Seeliger; E Nagel; J Westermann; M Schedlowski
Journal:  J Neuroimmunol       Date:  1998-08-01       Impact factor: 3.478

10.  Pavlovian conditioning of LPS-induced responses: effects on corticosterone, splenic NE, and IL-2 production.

Authors:  L J Janz; J Green-Johnson; L Murray; C Y Vriend; D M Nance; A H Greenberg; D G Dyck
Journal:  Physiol Behav       Date:  1996-06
View more
  7 in total

Review 1.  Placebo effects: clinical aspects and neurobiology.

Authors:  Barry S Oken
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

2.  Conditioned pharmacotherapeutic effects: a preliminary study.

Authors:  Robert Ader; Mary Gail Mercurio; James Walton; Deborra James; Michael Davis; Valerie Ojha; Alexa Boer Kimball; David Fiorentino
Journal:  Psychosom Med       Date:  2009-12-22       Impact factor: 4.312

Review 3.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

4.  Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage.

Authors:  Mehmet Erşahin; Hale Z Toklu; Sule Cetinel; Meral Yüksel; Can Erzik; M Zafer Berkman; Berrak C Yeğen; Göksel Sener
Journal:  Neurochem Res       Date:  2009-10-13       Impact factor: 3.996

5.  Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.

Authors:  Michael Dietrich; Niklas Helling; Alexander Hilla; Annemarie Heskamp; Andrea Issberner; Thomas Hildebrandt; Zippora Kohne; Patrick Küry; Carsten Berndt; Orhan Aktas; Dietmar Fischer; Hans-Peter Hartung; Philipp Albrecht
Journal:  J Neuroinflammation       Date:  2018-03-07       Impact factor: 8.322

Review 6.  Animal models of multiple sclerosis--potentials and limitations.

Authors:  Eilhard Mix; Hans Meyer-Rienecker; Hans-Peter Hartung; Uwe K Zettl
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

Review 7.  Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.

Authors:  Fanni Tóth; Edina Katalin Cseh; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.